171 related articles for article (PubMed ID: 16567341)
1. Relation of haemofilter type to venous catheter resistance is crucial for filtration performance and haemocompatibility in CVVH--an in vitro study.
Unger JK; Haltern C; Portz B; Dohmen B; Gressner A; Rossaint R
Nephrol Dial Transplant; 2006 Aug; 21(8):2191-201. PubMed ID: 16567341
[TBL] [Abstract][Full Text] [Related]
2. Albumin and hydroxyethyl starch 130 kDa/0.4 improve filter clearance and haemocompatibility in haemo- and plasmafiltration--an in vitro study.
Unger JK; Haltern C; Dohmen B; Gressner A; Grosse-Siestrup C; Groneberg DA; Rossaint R
Nephrol Dial Transplant; 2005 Sep; 20(9):1922-31. PubMed ID: 15928101
[TBL] [Abstract][Full Text] [Related]
3. Maximal flow rates and sieving coefficients in different plasmafilters: effects of increased membrane surfaces and effective length under standardized in vitro conditions.
Unger JK; Haltern C; Dohmen B; Rossaint R
J Clin Apher; 2002; 17(4):190-8. PubMed ID: 12494412
[TBL] [Abstract][Full Text] [Related]
4. Extracorporeal circuit pressure profiles during continuous venovenous haemofiltration.
Ejaz AA; Komorski RM; Ellis GH; Munjal S
Nurs Crit Care; 2007; 12(2):81-5. PubMed ID: 17883632
[TBL] [Abstract][Full Text] [Related]
5. Influence of acidaemia and hypoxaemia on CVVH haemocompatibility in a porcine model.
Bedarf JR; Russ M; Ott S; Keckel T; Kirschfink M; Unger JK
Nephrol Dial Transplant; 2010 Sep; 25(9):2960-9. PubMed ID: 20231150
[TBL] [Abstract][Full Text] [Related]
6. Continuous arteriovenous hemofiltration: in vivo functional characteristics and its dependence on vascular access and filter design.
Olbricht CJ; Haubitz M; Häbel U; Frei U; Koch KM
Nephron; 1990; 55(1):49-57. PubMed ID: 2352578
[TBL] [Abstract][Full Text] [Related]
7. Influence of different heparin concentrations on the results of in vitro investigations in plasmaseparation technology using capillary membrane filters.
Unger JK; Haltern C; Dohmen B; Rossaint R
Artif Organs; 2003 Jul; 27(7):649-57. PubMed ID: 12823420
[TBL] [Abstract][Full Text] [Related]
8. Dual-lumen catheters for continuous venovenous hemofiltration: limits for blood delivery via femoral vein access and a potential alternative in an experimental setting in anesthetized pigs.
Unger JK; Pietzner K; Francis RC; Birnbaum J; Theisen MM; Lemke AJ; Niehues SM
Crit Care; 2007; 11(1):R18. PubMed ID: 17302971
[TBL] [Abstract][Full Text] [Related]
9. Impact of inverse plasma filtration on complement activation in porcine blood.
Haltern C; Kirschfink M; Rossaint R; Unger JK
Artif Organs; 2005 Apr; 29(4):306-12. PubMed ID: 15787625
[TBL] [Abstract][Full Text] [Related]
10. Hydroxyethyl starch 130 kd/0.4 and albumin improve CVVH biocompatibility whereas gelatin and hydroxyethyl starch 200 kd/0.5 lead to adverse side effects of CVVH in anesthetized pigs.
Unger JK; Haltern C; Kobela JB; Francis R; Rossaint R; Grosse-Siestrup C
Shock; 2006 May; 25(5):533-45. PubMed ID: 16680020
[TBL] [Abstract][Full Text] [Related]
11. The effect of adsorption, filter material and point of dilution on antibiotic elimination by haemofiltration an in vitro study of levofloxacin.
Choi G; Gomersall CD; Lipman J; Wong A; Joynt GM; Leung P; Ramsay SJ; Ho OM
Int J Antimicrob Agents; 2004 Nov; 24(5):468-72. PubMed ID: 15519479
[TBL] [Abstract][Full Text] [Related]
12. Enhancing filtration rates by the use of blood flow around the capillaries of plasmafilters: an in vitro study.
Unger JK; Janssen VR; Kashefi A; Haltern C; Klosterhalfen B; Fischer Y; Gressner AM; Rossaint R
Int J Artif Organs; 2001 Nov; 24(11):821-31. PubMed ID: 11797853
[TBL] [Abstract][Full Text] [Related]
13. Assessment of temporary dialysis catheter performance on the basis of flow and pressure measurements in vivo and in vitro.
Kindgen-Milles D; Kram R; Kleinekofort W
ASAIO J; 2007; 53(3):351-6. PubMed ID: 17515728
[TBL] [Abstract][Full Text] [Related]
14. The effect of circuit "down-time" on uraemic control during continuous veno-venous haemofiltration.
Fealy N; Baldwin I; Bellomo R
Crit Care Resusc; 2002 Dec; 4(4):266-70. PubMed ID: 16573439
[TBL] [Abstract][Full Text] [Related]
15. Brain natriuretic peptide is removed by continuous veno-venous hemofiltration in pediatric patients.
Ricci Z; Garisto C; Morelli S; Di Chiara L; Ronco C; Picardo S
Interact Cardiovasc Thorac Surg; 2009 Jul; 9(1):33-6. PubMed ID: 19339274
[TBL] [Abstract][Full Text] [Related]
16. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
Shah PS; Kalyn A; Satodia P; Dunn MS; Parvez B; Daneman A; Salem S; Glanc P; Ohlsson A; Shah V
Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
[TBL] [Abstract][Full Text] [Related]
17. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
Sefer S; Kes P; Raić B; Heinrich B; Degoricija V; Szavits-Nossan J
Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
[TBL] [Abstract][Full Text] [Related]
18. How much is catheter flow influenced by the use of closed luer lock access devices?
Eloot S; De Vos JY; Hombrouckx R; Verdonck P
Nephrol Dial Transplant; 2007 Oct; 22(10):3061-4. PubMed ID: 17597088
[TBL] [Abstract][Full Text] [Related]
19. Clot formation in angiographic catheters--an in vitro comparative study. Effects of heparin and protein coating of the catheter.
Raininko R; Söder H
Acta Radiol; 1993 Jan; 34(1):78-82. PubMed ID: 8427754
[TBL] [Abstract][Full Text] [Related]
20. Continuous venovenous renal replacement therapy with a pulsatile tubular blood pump: analysis of efficacy parameters.
López-Herce J; Rupérez M; Sánchez C; García C; García E; Rodríguez D; Del Cañizo JF
Artif Organs; 2006 Jan; 30(1):64-9. PubMed ID: 16409399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
